I just noticed my message from yesterday was deleted as
I just noticed my message from yesterday was deleted as well. The funny thing is that several folks commented positively about it and one even said that it should be stickied.
Excellent post VIP!!
There are many fudsters on this board and the reason simply is money. Yes...money is to be gained by the criminal group who we believe hold a significant naked short position in IPIX. There are many players in this group. The large players are hedge fund(s), market makers, and possibly one or more large pharmaceutical companies. The hedge fund(s) and MM's want to see IPIX fail because if IPIX fails and goes into bankruptcy, their large naked short position will NEVER have to be covered and they will have a much smaller chance of being prosecuted for their illegal trading activities. If your a large pharmaceutical company, you don't want to see B or K ever reach the market because it may hurt the sales of their existing drugs. It is all about the MONEY with these entities!!
They thought they had buried IPIX with the bogus lawsuit they brought against IPIX several years ago. During the lawsuit, their overconfidence probably caused them to have significantly increased their illegal naked short position.
They never thought a money strapped company like IPIX would be able to get the lawsuit dismissed and they never thought that COVID-19 would give IPIX an additional opportunity to move their Brilacidin drug forward.
During these years, there have been individuals making thousands of negative posts against IPIX and its CEO. WHY???? There are a few traders who hope they can induce others to buy or sell their shares for their gain. The majority of fudsters are paid by the big players named above to post and spread disinformation. Some of these individuals use a VPN which allows them to post under multiple aliases.
None of these players ever expected IPIX to still be operating at this time or that the many old longs would still be holding onto their shares despite their intense efforts to drive the share price down.
If you believe in the science like I do and its ability to help the world, then you hold onto your shares and ignore whatever fud is thrown at us. It may have taken longer than we ever expected, we might have more stock dilution that we had hoped for but I believe we will win this war.
Dr. DeGrado, one of the premier medical scientists in the USA who helped co-develop Brilacidin 20 years ago, an individual who knows more about Brilacidin's capabilities than anyone on this board or in our country, affirmed his belief in Brilacidin by joining this company as a consultant this past month.
There is much at stake financially for the fudsters and their backers and there is much at stake both financially and medically for those of us who believe in IPIX. If the fudsters weren't worried they wouldn't keep posting day after day the same negative crap.
Time will tell, but I believe that in the near future, all of us longs will be very, very happy with our investment in IPIX.
15
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
LV Petroleum's Bold Moves in July Ever seen a company expand across four states in a blink? LV Petroleum's been hustling like a player with a fresh hand of aces. They shut July down with restaurant openings and a fancy new travel center under their belt in states as spread out as Arizona, Texas, Nevada, and Ohio. Now that's a wide net they're casting, all in the name of...
Continue Reading
The Safety Maverick Steps into Healthcare They've gone and done it—appointed a rockstar of systems safety to ECRI's Board of Trustees. Professor Najmedin Meshkati, who's practically been around every major industrial accident of the past few decades, is about to shake things up. Imagine the guy who's dissected calamities like the BP Texas City Refinery explosion and the...
Continue Reading
A Breath of Fresh Air for the Auto Aftermarket How often do you even think about the quality of air inside your vehicle? If you're like most folks, it's not often. But Premium Guard Inc. (PGI) has been busy changing that narrative. Their Febreze Cabin Air Filters just snagged the 2026 MOTOR Top 20 Awards, proving that they're not just a pretty face in the automotive...
Continue Reading
Every once in a while, the machinery scene gets rocked by something that genuinely raises eyebrows, and it seems Chuan Lih Fa Machinery Works Co., Ltd. (CLF) has just delivered one of those moments. This isn't just any old injection molding machine—it's Taiwan's very first 5000-ton giant, crafted with robust precision and dispatched straight to a major U.S. logistics...
Continue Reading
Moving Pieces in the Automotive Puzzle Here's one for the books, folks. Automotive dealership chessboard gets another shuffle. Scott Gruwell, the big wheel behind Courtesy Automotive Group, has snatched up Watson Chevrolet and Infiniti of Tucson. Just one more notch in someone's power belt—operations now rolling under new banners as Courtesy Chevrolet and Courtesy...
Continue Reading
Where Beef Snacks Meet Road Tales Just a year ago, Ribbonwire Ranch, a small Texas-based beef snack producer, made its debut at Sheetz stores. Now, they're not just another brand on the shelf; they're weaving tales from the road with their latest venture, the "Dashboard Diaries" campaign. If you're wondering how a beef snack producer finds itself in an eight-week...
Continue Reading
Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...
Continue Reading
Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...
Continue Reading
Expansion in Full Swing In a move that might get tongues wagging in the boardrooms across Israel, Max Stock Limited (TASE: MAXO) just signed a hefty lease for a logistics center in Ofakim. This isn't just a modest expansion—it's a jaw-dropper at about 45,000 square meters. We're talking about a major upgrade that'll beef up their logistical backbone as they continue...
Continue Reading
Every so often, an artist comes around who's not just making music but shifting the very landscape of their genre. Beyoncé isn't just marking her birthday today; she's reminding the world of a career-defining moment with the release of her remastered deluxe version of 'B'DAY'. This isn't just a stroll down memory lane; it's a full-blown revival of an era that reshaped...
Continue Reading
Top 5 Most Recently Viewed Articles
Exploring Current Trends in the Options Market for Nano Nuclear Energy Recent movements among financial giants suggest a notable bearish sentiment surrounding Nano Nuclear Energy. Analyzing the options history for Nano Nuclear Energy (NNE), we have identified 12 unusual trades that indicate evolving market perspectives. In our detailed assessment, we discovered that...
Continue Reading
Promising Developments in CAR-T Therapy with NT-I7 NeoImmuneTech, Inc. has achieved significant advancements in enhancing CAR-T cell therapies, which are innovative treatments designed to combat cancer. Recent interim results from the Phase 1b clinical trial demonstrate the potential benefits of combining NT-I7 (efineptakin alfa) with CAR-T therapy, highlighting its...
Continue Reading
Owkin made headlines back in 2024 when it teamed up with AstraZeneca, looking to revolutionize breast cancer diagnostics by developing an advanced tool for pre-screening gBRCA mutations. Traders were quick to pick up on this collaboration, given the critical nature of BRCA testing and its potential market impact. But let’s peel back the layers on this deal. Partnership...
Continue Reading
Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....
Continue Reading
Wellness Workdays Unveils the 2026 Best Wellness Employer Survey In a significant move towards enhancing employee health and wellness, Wellness Workdays has launched the 2026 Best Wellness Employer survey. This initiative invites organizations to showcase their dedication to improving workplace well-being through sustainable practices and measurable results. Collaboration...
Continue Reading